Question · asked by 1 review

Tranexamic acid vs placebo + standard care: Control of epistaxis: episodes of re‐bleeding over 10 days Topical application (10% gel) only

Population
adults with nasal haemorrhage (epistaxis)
Intervention
Tranexamic acid
Comparison
placebo + standard care
Outcome
Control of epistaxis: episodes of re‐bleeding over 10 days Topical application (10% gel) only

Tranexamic acid showed no clear difference in control of epistaxis: episodes of re‐bleeding over 10 days Topical… compared with placebo plus usual care or usual care alone (low certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Tranexamic acid vs placebo plus usual care or usual care alone
Control of epistaxis: episodes of re‐bleeding over 10 days Topical application (10% gel) only · adults with nasal haemorrhage (epistaxis)
Tranexamic acid showed no clear difference in control of epistaxis: episodes of re‐bleeding over 10 days Topical… compared with placebo plus usual care or usual care alone (low certainty).
Tranexamic acid for patients with nasal haemorrhage (epistaxis) (2018) · Cochrane Headline outcomes only
RR 0.66 [0.41, 1.05]1 study · 68 participantsLow

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Tranexamic acid for patients with nasal haemorrhage (epistaxis)
2018 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed
How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.